Excess Mortality and Long-Term Disability from Healthcare-Associated Staphylococcus aureus Infections: A Population-Based Matched Cohort Study
Open Access
- 6 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71055
Abstract
Staphylococcus aureus is a leading cause of healthcare-associated infections (HAIs), but the impact of S. aureus HAIs on the long-term survival and functional status of hospitalized patients remain unknown. This study aimed to examine whether S. aureus HAIs increase the risks for long-term mortality and disability. We conducted a retrospective population-based matched cohort study of inpatients at 8 medical centers, 43 regional hospitals, and 63 local hospitals which participated in the Taiwan Nosocomial Infection Surveillance (TNIS). We individually matched 3070 patients with S. aureus HAIs to 6140 inpatients without HAIs at a 1∶2 ratio by age, gender, hospital, specialty, underlying diseases, and the length of stay before onset of the S. aureus HAI. Main outcome measures are one-year excess risks for mortality, new-onset chronic ventilator dependence, and new-onset dialysis-dependent end-stage renal disease. We found that patients with S. aureus HAIs had an excess one-year mortality of 20.2% compared with matched uninfected inpatients (PPsS. aureus HAIs were also associated with an excess hospital stay of 12 days and an extra cost of $5978 (PsS. aureus HAIs have substantial negative effect on the long-term outcome of hospitalized patients in terms of both mortality and disability, which should be taken into consideration in future cost-effectiveness studies of the control and prevention interventions for S. aureus HAIs.Keywords
This publication has 30 references indexed in Scilit:
- Effectiveness and Limitations of Hand Hygiene Promotion on Decreasing Healthcare–Associated InfectionsPLOS ONE, 2011
- Emergence and spread of multi-drug resistant organisms: Think globally and act locallyJournal of Microbiology, Immunology and Infection, 2011
- Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureusNew England Journal of Medicine, 2010
- Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes StudyPLOS ONE, 2009
- The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitalsThe European Journal of Health Economics, 2008
- The Impact of Antimicrobial‐Resistant, Health Care–Associated Infections on Mortality in the United StatesClinical Infectious Diseases, 2008
- Methicillin-resistant Staphylococcus aureus on orthopaedic wardsThe Journal of Bone and Joint Surgery. British volume, 2006
- Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcomeJournal of Antimicrobial Chemotherapy, 2006
- Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Causing Nosocomial Infections at a University Hospital in Taiwan from 1986 to 2001Antimicrobial Agents and Chemotherapy, 2004
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003